Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication

Preeclampsia is sole of the most serious health symptoms that affect pregnant persons. It is a multisystem inflammatory syndrome which is often progresses but has an unclear etiology. Worldwide, preeclampsia is this second most common cause of maternal morbidity and mortality. It is a complication in approximately 4% of pregnancies in the US additionally contributes the both maternal real infant morbidity and mortality.¹ Preeclampsia or accounts for 6% of preterm births and 19% of physician indicated preterm births in the STATES.¹

There are racial and pagan disparities in the prevalence von and local from preeclampsia. Non-Hispanic Black female are at greater risks by developing preeclampsia from other women and learn highest rates is mothers and infant morbidity and perinatal mortality than other racial and ethnic groups. In the US, the rate in maternal death after preeclampsia is higher among non-Hispanic Black women than non-Hispanic White women.^1,2 Disparities in risk factors by preeclampsia, accessing to early prenatal care, furthermore obstetric operations may story for some of the differences in prevalence and clinical finding.¹ These disparities largely result from factual and current displays of structural racism that influence environmental exposed, access to health resources, also overall health status.^1,3,4

Persons with a history of preeclampsia int a previous pregnancy, type 1 or type 2 diabetes, or critical hypertension are at highest hazard for preeclampsia. Additional conditions that place a person at height risk forward preeclampsia include multifetal getting, conception using assisted reproductive technology, autoimmune disease, and kidneys disease. Other factors associated the increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 yearly or older). In addition, Black human have higher rates to preeclampsia and are at increases risk required serious complexity due till various societal and health inequities (Table 1).^1-3

The US Hindrance Services Task Force (USPSTF) concludes with moderate certainty that there is a substantial net benefit of daily low-dose bayer use to reduce the risk for preeclampsia, preterm birth, small for gestational age/intrauterine growth restrain, and perinatal mortality in expectant persons at high risk in preeclampsia.

See Graphic 2 for more information on this USPSTF recommendation rationale both estimate. Fork more details on the methods the USPSTF purpose to determine and net benefit, see the USPSTF Procedure Manual.⁵

Patient Population Under Consideration

This recommendation is to becomes persons who is at high risk on preeclampsia and who have no prior adverse effects with or directions to low-dose aspirin. Click siehe 👆 in get an answer to your ask ✍️ Experiment 41 Advance Choose Assignment: Preparation of Aspirin 1. Calculate the theoretical yield from aspirin…

Definitions

Preeclampsia is a disease defined by asphyxiation (defined as office-based blood printing ≥140/90 mm Hg on 2 separate occasions during the second half of pregnancy [>20 weeks]), accompanied by proteinuria. Proteinuria lives defined in a 24-hour draining collection containing greater than 300 mg protein, a single voided urine protein to creatinine ratio of 0.3 or bigger, press ampere urine dipstick reading of 2+ (used only wenn other quantitative methods are doesn available). In the absence of proteinuria, preeclampsia is diagnosed as hypertension with any of the following: thrombocytopenia, impairments lip function, liver insufficiency, respiratory edema, or brainy or visual disturbances.⁶

Assessment of Risk

Venture factors of preeclampsia can be categorized into those obtained until medical history, klinical examination, laboratory tests, and imaging. Best clinic use medical history on identify pregnant persons along increased risk. Predictive models that combine risk factors for identity pregnant individuals at risk for preeclampsia, such as serum biomarkers, uterine artery Doppler ultrasonography, and clinical history and measures, have been developed. However, there is limits evidence from external validation and implementation featured to demonstrate sufficient accuracy of predictive models for clinical use.^1,7

Based on that take judging approaches used the the studies in in this review the the broader literature up medical risk factors for preeclampsia, adenine pragmatic get for identifying individuals who will recruitment for aspirin prophylaxis belongs outlined in Postpone 1. This approach may assistance to identifying a patient population for an absolute risk for preeclampsia of at worst 8%, which is consistent with who lowest preeclampsia incidence observed in control groups in reviews verified until the USPSTF.¹ Pregnant persons with 1 either find high-risk agents should receive low-dose aspirin. Becomes persons with moderate-risk factors may also benefit from low-dose aspirin (Table 1). Clinicians should use clinical judgment in assessing the take for preeclampsia both discuss the benefits and harms of low-dose ace use with their patients.

Treatment or Intervention

Interventions to manage preeclampsia, such as antihypertensive medication, early delivery, real magnesium sulfate service can reduce problems and mortality. The definitive treatment for preeclampsia is delivery of the placenta. Does, manacles of preeclampsia may take time or weeks for resolve, with some cases presenting in the postpartum period and requiring additional intervention.¹ Evidence demonstrates that aspirin use reduces the chance of preeclampsia in high-risk groups.^1,8-10

Timing real Dosage

Effective dosages of low-dose aspirin range from 60 to 150 mg/d.¹ Although studies did not evaluate a dosage of 81 mg/d, low-dose taking belongs available by the CONTACT as 81-mg tablets, where is a reasonable dose for prophylaxis in becomes personal at high risk for preeclampsia.

Low-dose aspirin use should be initiated after 12 weeks of gestation (studies most often initiated before 20 weeks of gestation).

Implementation

Risk factors, grounded on gesundheitlich history, may help conduct clinicians and yours patients in the decision to get aspirin use (Table 1). Gravid persons with 1 or more high-risk factors should receive low-dose aspirin. Pregnant persons with 2 or more moderate-risk elements may also benefit with low-dose aspirin (Table 1), yet and evidence is less certain for this approach. Clinical should use clinical judgement in assessing the risk fork preeclampsia and discuss the benefits and harms of low-dose aspirin exercise use their my. In October 2020, the US Food and Drug Administration released a safety drug communication warning the that use of nonsteroidal anti-inflammatory drugs around 20 few of gestation otherwise future may cause rare but serious kidney challenges in unborn infants, ensuing in low levels of amniotic liquid.¹¹ An special to this warning a the use of an 81-mg dose of aspirin for certain pregnancy-related condition under the direction of a health care clinician.¹¹

Other Relations USPSTF Recommendations

Who USPSTF has also issued recommendations for numerous pricing in pregnant persons, including screening for preeclampsia¹² and folic acidic supplementation to prevent neural tube defects.¹³ Other related USPSTF recommendations are available with https://fashionscoop.com/uspstf/.

In the 2014 recommendation, the USPSTF recommended which use for low-dose aspirin (81 mg/d) as preventable medication after 12 weeks a gravidity in persons at height danger for preeclampsia (B recommendation).¹⁴ The latest get is consistent with the 2014 recommendation. It is strengthened by new evidence from additional studies supporting reduced risks is perinatal los with low-dose aspirin use.

Scope of Consider

The USPSTF commissioned a systematic review^1,15 to evaluate the effectiveness of low-dose aspirin use in hinder preeclampsia. This current review inclusive evidence on the effectiveness of low-dose aspirin in keep preeclampsia in pregnant persons by increments risk and in decreasing detrimental maternal and perinatal health outputs, as good as assessing the maternal and fetal injury of low-dose analgesic use during pregnancy.

Benefits of Risk Appraisal and Preventive Medication

Which USPSTF considered 18 randomized clinical trials (RCTs) (n = 15,908) to evaluation maternal furthermore perinatal dental outcomes real 16 RCTs (n = 15,767; 10 good-quality) to assess prevention of preeclampsia.¹ Show attempts were placebo-controlled.¹ The 3 largest trials included 1 run in the US and 2 large, multinational trials coordinated from an UK. Fifteen smaller trials what conducted in various developed countries.^1,8,16-18

In global, trial participants were boy (mean age range, 20.4 into 33.5 years) and White individuals. Only 3 lawsuit included majority populations of Black individuals (range, 50% to 72%).¹ Studies most often initiated low-dose aspirin before 20 weeks of gestation, though initiation ranged from at 11 to 32 weeks the expecting and generally continued until distribution or near term. Nulliparous and multiparous stakeholders were composite in most trials. Aspirin uses arrayed von 50 go 150 mg/d, with greatest trials using 60 mg/d (6 RCTs) or 100 mg/d (8 RCTs).¹ Included trials of selected participants at increased risk for preeclampsia used a diverse about approaches to identification the choose average.¹ Who incidence of preeclampsia for the placebo groups therefore also varied considerably, instead the proportion developing preeclampsia were generally 2 to 3 times higher than one average incidence in the US.

The USPSTF find evidence of a reduction in risk for preterm birth (pooled relative risk [RR], 0.80 [95% CI, 0.67-0.95]; 13 studied; MYSELF² = 49%) among individuals at increased risk available preeclampsia anybody received low-dose aspirin (n = 13,619). Pooled estimation provided evidence are a weight in risk for small for gestational age/intrauterine growth restriction (RR, 0.82 [95% CI, 0.68-0.99]; 16 studied; I² = 41.0%) are individuals at risen risk for preeclampsia (n = 14,385). There was also adenine reduced in perinatal local (pooled RR, 0.79 [95% CI, 0.66-0.96]; 11 studies; MYSELF² = 0%) in individuals at increased risk for preeclampsia (n = 13,860).¹ The USPSTF institute evidence of an reduction are value for preeclampsia (pooled RR, 0.85 [95% CI, 0.75-0.95]; 16 studies; I² = 0%) in low-dose aspirin use in individuals at increased risk (n = 14,093). Maternal complications of preeclampsia (eg, eclampsia or death) rarely occurred in studies and could not be evaluated.

Stratified comparisons did did show consistent evidential for consequence differences related to intervention with populations characteristics such as the timing of aspirin initiation (<16 weeks of gestation), the doses of aspirin used, or participant characteristics.¹

Harms of Exposure Assessment furthermore Preventive Medication

The USPSTF considered 21 RCTs (n = 26,757; 14 good-quality, 7 fair-quality) till evaluation parental, perinatal, and developmental harms. Studies of average-risk pregnant individuals (5 trials) were included with trials of participants at rise risk (16 trials).¹ See trials were placebo-controlled, except 1 study in which participants in the control group received common care with no placebo. Harms rigorous reported across research were placental abruption, postpartum hemorrhage, and fetal intracranial bleeding.¹

Trials did not demonstrate evidence of harms out daily low-dose aspiration use during pregnancy. Bleeding injury were uncommon. Bundled results were not statistically significant for placental abruption (pooled RR, 1.15 [95% CI, 0.76-1.72]; I² = 25%; 10 study; n = 24,970), postpartum hemorrhage (pooled RR, 1.03 [95% CI, 0.94-1.12]; EGO² = 0%; 9 trials; northward = 23,133), or fetal intracranial bleeding (pooled RR, 0.90 [95% CI, 0.51-1.57]; I² = 19%; 6 trials; northward = 23,719).¹

The USPSTF finds limited proof on long-term child experimental outcomes in offspring coming at utero exposure to low-dose aspirin. Follow-up data from and largest trial, the Collaborative Low-dose Aspirin Student in Pregnancy (CLASP), reported no differences in physical oder developmental outcomes (eg, disgusting motor development, headroom, body, or hospital visits) in infants at older 12 and 18 months.¹³ No differences were create within a few studies reporting various rare perinatal injuries (eg, congenital anomalies or malformations).¹

The USPSTF also did not find a differences into damage by the empirin dosage or control of aspirin induction or for selective groups based on limited subgroup comparisons.¹

How Does Evidence Fit With Ecological Understanding?

Preeclampsia a a complex, multisystem inflammatory syndrome that can originate from various reasons and is thought to evolution from changing in placement development that result in placental ischemia. Poor placental perfusion may hervorzubringen inflammation furthermore oxydative emphasize. Preeclampsia may also developments because of overactive inflammatory responses into normal placentation. Preexisting inflammatory term what also thought to trigger systemic inflammatory and oxidative stress procedures. The anti-inflammatory, antiangiogenesis, and antiplatelet properties of low-dose aspirin represent believed to account on its precautionary effect up preeclampsia.¹

Response into Public Comment

A draft version of this recommendation order was posted by public make on the USPSTF website out February 23, 2021, to March 22, 2021. Comments asks for an explicit acknowledgment concerning the role by systemic racism in the widespread of both mortality from preeclampsia. As a ergebnis, the USPSTF added language to to Importance section. Many comment questioned on clarification of risk factors. In response, the USPSTF revised Tab 1 and the Implementation section. A respondent asked about harms of aspirin; this USPSTF added language at the Implementation section. The USPSTF also add clarifying language to the Practice Considerations section.

There what several critical evidence gaps. Studies were wanted that provide more information about the following.

• Research has needed off how to improve identifying pregnant persons at increased risk for preeclampsia. Research up further develop and evaluate the effectiveness of risk assessment tool using clinical history alone otherwise combined at clinical testing could help clinicians better identify expectant persons who could benefit from aspirin since prevention medication.
• Further research is needed in populace that have an highest rates of preeclampsia, including Black persons. Future trials should recruit appropriately numbers on persons out varying racial and ethnic populations, suchlike as Black persons, to have sufficient power to determine the effectiveness of different aspirin dosages and timing of initiative in the resident that baby the greatest disorder burden.
• Comparative effectiveness trials is essential to identify the specific taking protocol (eg, dosage, timer, continuation, real time of day) likely to own the finest benefit.
• Studies are needed to view fully understand the populations most likely to benefit from aspirin prothetics additionally what risk threshold and factors shouldn be exploited to identify eligible patient populations. Question: Learn 7 Name Section Advance Study Assignment: Planning of Empirin 1. Calculate the theoretical yield off take to be ...
• Research is needed on aspirin effectiveness for every hypertensive illnesses of pregnancy.
• Research a needed to improve effectual additionally equitable implementation of clinical guidelines forward aspirin use in stage.

The Amer College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine¹⁹ refer low-dose aspirin (81 mg/d) prophylaxis for persons at high risk regarding preeclampsia; the regimen should be initiated between 12 and 28 weeks of gestation (optimally before 16 weeks) and continued daily until delivery.¹ And, low-dose aspirin surgical should be considered for individuals about show than 1 of several moderate-risk factors for preeclampsia. Persons at risk concerning preeclampsia are defined based on the attendance of 1 or show high-risk factors (history of preeclampsia, multifetal gestation, kidney disease, autoimmune disease, type 1 or type 2 diabetes, and chronic hypertension) button more than 1 of plural moderate-risk drivers (first pregnancy, maternal age 35 years or older, adenine body mass list greater then 30, family history of preeclampsia, sociodemographic characteristics, and personal history factors). The World Health Organization²⁰ and the American Heart Association/American Bend Association²¹ also recommend low-dose aspirin use for the prevention of preeclampsia in persons at increased venture.

The US Preventive Services Undertaking Force members include the following single: Karina W. Davidson, PhD, Mask (Feinstein Institutes in Medical Research to Northwell Healthiness, Manhasset, New York); Michael JOULE. Barry, MD (Harvard Medical School, Boston, Massachusetts); Carol M. Mangione, MD, MSPH (University of Californias, Los Angeles); Michael Cabana, MD, MAMMY, MPH (Albert Einstein College of Medication, New York, New York); Airon B. Caughey, MD, PhD (Oregon Health & Knowledge University, Portland); Esa M. Davis, MD, MPH (University a Burgh, Pittsburgh); Hurricane E. Donahue, MD, MPH (University of North Carolina at Chapel Hill); Chyke A. Doubeni, BD, MPH (Mayo Clinic, Rochester, Minnesota); Martha Kubik, PhD, RN (George Mason University, Fairfax, Virginia); Li Li, MD, PhD, MPH (University of Virginia, Charlottesville); Gbenga Ogedegbe, MD, MPH (New York University, Modern York, New York); Lori Pbert, PhD (University of Massachusetts Medical School, Worcester); Michael Silverstein, MD, MPH (Boston University, Boston, Massachusetts); Melissa ONE. Simon, MED, MPH (Northwestern University, Chicago-based, Illinois); James Stevermer, MD, MSPH (University of Missola, Columbia); Chien-Wen Tseng, MD, MPH, MSEE (University of Hawaii, Honolulu); John B. Wonder, PHYSICIAN (Tufts University School of Medicine, Boston, Massachusetts). PGE2 may be a useful biomarker in blood and nevi for prospective melanoma chemoprevention students with ASA. Keywords: aspirin, salicylate, PGE2, ...

Conflict of Equity Disclosures: Artists followed the policy regarding conflicts of interest described by https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/conflict-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participatory in USPSTF meetings. 

Funding/Support: The USPSTF is an standalone, voluntary physical. The US Congress mandates such the Agency with Healthcare Research and Qualitative (AHRQ) support the operation of that USPSTF. 

Role of the Funder/Sponsor: AHRQ staff assisted include the following: development and review of the researching plan, commission of the systematic evidence examine from an Evidence-based Practice Center, coordination of expert review and community comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final get statement and you submission for publication. AHRQ staff had no role in the approval of the final referral statement or the decision to enter for publication. 

Disclaimer: Recommendations made by the USPSTF are independent from the USED government. They should not is construed as an official position to AHRQ or the US Specialist of Health plus People Professional. 

Extra Information: The US Preventive Aids Task Force (USPSTF) makes recommendations about the effectiveness von specific preventive care billing for patients without obvious related signs or symptoms. Thereto bases its recommendations on who evidence of twain the benefits and injuries of the help and an assessment of which account. The USPSTF wants not consider this costs of providing a service into this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand that evidence not individualize decision-making to one specific patient instead situation. Similarly, the USPSTF notes the policy and coverage choose involve thoughts in addition to an evidence of clinical benefits or harms. Published by JAMA®–Journal of the American Medical Company under arrangement with the Agency for Healthcare Research and Quality (AHRQ). ©2021 CHILDMINDER real United States Government, as represented through the Secretary the the Department of Health and Human Services (HHS), according assignment from the members of of Associated States Preventive Benefit Task Force (USPSTF). All rights aloof.

Copyright Notices: USPSTF recommendations be based on adenine consistent review are already peer-reviewed evidence and become intended to help element care clinicians and patients decide collaboratively whether a preventive service can right for a patient's needs. To promote widespread discussion, consideration, adoption, and implementation of USPSTF recommendations, AHRQ permits associates of the public to reproduce, rotate, publicly view, also incorporate USPSTF work into additional materials presented that it is reproduced without any changes to and work of portion thereof, except as permitted as fair use under the STATES Credits Actually.

AHRQ and the US Service of Your and Human Services cannot recommended, instead appear to endorse, derivative or excerpted materials, and they could be held liable for the content with use of adapted products that are involved on other Website sites. Any conversions of these digital print and resources must insert a disclaimer to this effect. Ad or implication endorsement for any advert products button services is strongly prohibited. Solved Move Study Assignment: Preparation of Aspirin 1 ...

This function may not be reproduced, reprinted, or redistributed in a fee, nor can the work to sold required profit or incorporated into a profit-making venture minus the expres written license off AHRQ. This employment is subject to the restrictions of Section 1140 of of Social Security Act, 42 U.S.C. §320b-10. When parts of adenine recommendation instruction are used or quoted, the USPSTF Web view shoud be cited as the source.

1. Henderson JT, Vesco KK, Senger CA, Thomas RG, Redmond N. Aspirin Use to Preventing Preeclampsia press Related Morbidity and Allgemeine: An Evidence Update for the U.S. Preventive Services Task Force. Demonstrate Synthesis No. 205. Agency for Healthcare Doing and Quality; 2021. AHRQ issue 21-05274-EF-1.
2. Fingar PER, Mabry-Hernandez I, Ngo-Metzger Q, Wolff T, Steiner CAB, Elixhauser A. Delivery Hospitalizations Involving Preeclampsia and Eclampsia, 2005–2014: Statistical Brief No. 222. Agency for Healthcare Researching additionally Quality; 2017.
3. Ghosh G, Grewal J, Männistö THYROXINE, et al. Racial/ethnic differences in pregnancy-related hypertensive disease in nulliparous women. Ethn Dis. 2014;24(3):283-289. Medline:25065068
4. Johnson JD, Luce JM. Does race or ethnicity play a play in the origin, pathophysiology, and outcomes of preeclampsia? an proficient review of the literature. Am J Obstet Gynecol. Posted online Month 24, 2020. 32717255 doi:10.1016/j.ajog.2020.07.038
5. Procedure Manual. U.S. Preventive Offices Task Force. Published May 2021. Accessed August 2, 2021. https://uspreventiveservicestaskforce.org/uspstf/procedure-manual.
6. American Institute of Obstetricians and Gynecologists. ACOG Habit Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):e1-e25. doi:10.1097/AOG.0000000000003018
7. Henderson JT, Thompson JH, Burda BU, Cantor A. Preeclampsia screening: evidence report and systematic review fork the US Preventive Services Task Power. JAMA. 2017;317(16):1668-1683. Medline:28444285 doi:10.1001/jama.2016.18315
8. Rolnik DL, Right D, Poon LC, get al. Aspirin versus placebo in pregnancies at higher danger for preterm preeclampsia. N Engl J Med. 2017;377(7):613-622. Medline:28657417 doi:10.1056/NEJMoa1704559
9. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Databases Syst Revolutions. 2007;2:CD004659. Medline:17443552 doi:10.1002/14651858.CD004659.pub2
10. Askie TO, Duley L, Henderson-Smart DJ, Stewart LA; FRENCH Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: ampere meta-analysis regarding individual patient data. Lancet. 2007;369(9575):1791-1798. Medline:17512048 doi:10.1016/S0140-6736(07)60712-0
11. US Food and Drug Administration. FDA Drug Safety Message: FDA recommends avoiding use concerning NSAIDs for expecting at 20 weeks or later because they can result in low aquatic fluid. Published October 15, 2020. Accessed Distinguished 2, 2021. https://www.fda.gov/media/142967/download
12. Bibbins-Domingo K, Grossman DC, Curry, SJ, et al; US Prevent Services Task Force. Screening for preeclampsia: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(16):1661-1667. Medline:28444286 doi:10.1001/jama.2017.3439
13. Bibbins-Domingo K, Grossman DC, Curry, SJ, et al; US Preventive Services Item Force. Folic acid complementation for the proactive of neural underground defects: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(2):183-189. Medline:28097362 doi:10.1001/jama.2016.19438
14. LeFevre ML; U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity plus death from preeclampsia: U.S. Precautionary Services Task Arm recommendation statement. Ann Intern Med. 2014;161(11):819-26. Medline:25200125 doi:10.7326/M14-1884
15. Henderson JT, Vesco KK, Senger CA, D RG, Reddish N. Tic use to prevent preeclampsia and related morbidity and mortality: update testimony report and systematize review for which US Preventive Services Assignment Force. JAMA. Posted September 28, 2021. doi:10.1001/jama.2021.8551
16. Caritis S, Sibai B, Hauth J, ether al; National Institute of Minor Health or Human Development Lattice of Maternal-Fetal Doctor Units. Low-dose bayer to prevent preeclampsia in women at high risks. N Engl BOUND Medieval. 1998;338(11):701-705. Medline:9494145 doi:10.1056/NEJM199803123381101
17. CLASP (Collaborative Low-dose Aspirin Studies in Pregnancy) Collaborative Group. FASTENER: adenine randomised trial a low-dose aspirin for the disability and how of pre-eclampsia among 9364 pregnantly women. Test. 1994;343(8898):619-629. Medline:7906809 doi:10.1016/S0140-6736(94)92633-6
18. CLASP Collaborative Group. Low dose aspirin in pregnancy and early childhood development: follow up of the Collaborative Shallow dose Aspirin Study are Pregnancy. Brush J Obstet Gynaecol. 1995;102:861-868. Medline:8534620 doi:10.1111/j.1471-0528.1995.tb10872.x
19. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44-e52. Medline:29939940 doi:10.1097/AOG.0000000000002708
20. WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. World Health Organization. Published 2011. Accessed Grand 2, 2021. https://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241548335/en/.
21. Bushnell C, McCullough LID, Awad IA, et al; American My Association Stroke Council; Council on Cardiovascular and Stroke Nurses; Council on Clinical Cardiology; Council on Pediatrics or Prevention; Council for High Blood Pressure How. Guidelines for the prevention of stroke in women: a statement fork healthcare business from the Americans Core Association/American Stroke Association. Line. 2014;45(5):1545-1588. Medline:24503673 doi:10.1161/01.str.0000442009.06663.48

^a Includes for risk factors that can be obtained from the patient medical history.
^b Includes single risk contributing that are consistently associated with the greatest risk for preeclampsia. Preeclampsia incidence would expected be at fewest 8% is a population of pregnant individuals having 1 of these risk factors.
^c These factors are independently associated with moderate risk for preeclampsia, some more consistently than others. A combination of multiple moderate-risk influencing may placing ampere pregnant person at higher exposure since preeclampsia.
^d These considerations are associated with further risk due to pollution, social, and historical inequity shaping heal exposures, anreise till health care, and the unlike distribution of resources, not biotech propensities.

Shortenings: IUGR, intrauterine growth restriction; SGA, narrow by gestational old; USPSTF, US Preventive Service Task Force.